Skip to content
Open access

Clinical Performance of Nitrous Oxide Inhalation versus Intravenous Sedation in Outpatient Dental Surgery: Efficacy and Safety Outcomes

Jul 2026 · Community Based Medical Journal · 0 citations

TL;DR

Intravenous sedation is optimal for profound anxiolysis in complex cases, while nitrous oxide is ideal for routine procedures, prioritizing rapid recovery and fewer side effects.

Abstract

Selecting an optimal sedation technique is pivotal for balancing efficacy and safety in outpatient dental surgery. Nitrous oxide inhalation and intravenous sedation are widely used, yet comprehensive comparative data in similar clinical environments are needed to guide practice. The objective of this study was to prospectively compare the clinical efficacy, safety, and recovery profiles of nitrous oxide inhalation sedation versus intravenous midazolam sedation for outpatient dental surgical procedures. This prospective cohort study was conducted at Liberty Hospital Ltd. Paribagh, Shahbagh, Dhaka, Bangladesh, from January to December 2024. A purposive sample of 50 patients was allocated to receive either nitrous oxide/oxygen (n=25) or intravenous midazolam sedation (n=25). Efficacy was measured by procedure completion, operator satisfaction (10-point VAS), and patient-reported anxiety reduction. Safety outcomes included hemodynamic stability, adverse event incidence, and time to meet a modified Aldrete recovery score of ≥9. Data were analyzed using SPSS version 23.0. Both techniques achieved 100% procedure completion. Intravenous sedation provided superior operator satisfaction and greater anxiety reduction (p<0.001). However, nitrous oxide yielded a significantly faster recovery time (8.5 vs. 33.1 minutes, p<0.001) and lower rates of postoperative nausea (8.0% vs. 36.0%, p=0.021) and hypotension (4.0% vs. 32.0%, p=0.019). Hemodynamic changes were more pronounced with IV sedation. Intravenous sedation is optimal for profound anxiolysis in complex cases, while nitrous oxide is ideal for routine procedures, prioritizing rapid recovery and fewer side effects. The choice should be individualized based on patient factors and procedural demands.   CBMJ 2026 July: Vol. 15 No. 02 P:283-289

Read PDF

Similar papers

Open access Jul 2026

EFFICACY OF DEXMEDETOMIDINE VERSUS MIDAZOLAM FOR SEDATION IN PATIENTS UNDERGOING REGIONAL ANESTHESIA: A RANDOMIZED CONTROLLED STUDY

Objectives: The objective of the study was to assess the effectiveness and safety of dexmedetomidine versus midazolam for sedation during regional anesthesia surgery. Methods: This prospective randomized comparative interventional study was conducted in the Department of Anesthesiology at a tertiary care hospital from...

AVINASH KAREKAL, SRINIVAS KURAHATTI, Rashmi C · 0 citations
Review Open access Jul 2026

Propofol for palliative sedation: A systematic review of clinical outcomes, safety, and ethical implications.

Propofol may be considered as a rescue option in selected refractory cases managed by experienced teams; however, given the low to very low certainty of available evidence, findings should be interpreted cautiously and supported by institutional protocols and further prospective research.

Luís Almeida-Jardim, P. Reis-Pina · 0 citations
Open access Aug 2026

Characterizing the Safety and Efficacy of Propofol in Critically Ill Pediatric Patients.

Propofol was safely used to facilitate extubation and decreased baseline sedative exposure when used for sedation washout in a complex critically ill pediatric population and was tolerated by most patients at doses commonly exceeding guideline- recommended maximum rate and duration.

Benjamin Colwell, Ferras Bashqoy, Maria Spilios et al. · 0 citations
Open access Aug 2026

Total Intravenous vs Volatile Inhalational Anesthesia for Major Noncardiac Surgery: A Randomized Clinical Trial.

Among older adults undergoing major noncardiac surgery, TIVA did not improve days alive and at home at 30 days compared with inhalational anesthesia, and there were no differences in days alive and at home at 90 days; mortality at 30 days, 90 days, or 6 months; or Quality of Recovery-15 score at day 3.

S. Jhanji, Katie Booth, Louise Hiller et al. · 1 citation
Open access 2026

EFFICACY OF DEXMEDETOMIDINE VERSUS PROPOFOL INFUSION IN PRODUCING CONTROLLED HYPOTENSION DURING FUNCTIONAL ENDOSCOPIC SINUS SURGERY IN A TERTIARY CARE HOSPITAL

Background:Functional Endoscopic Sinus Surgery (FESS) requires a clear and bloodless surgical field for optimal visualization and prevention of intraoperative complications. Controlled hypotension is commonly employed during FESS to reduce blood loss and improve surgical conditions. Dexmedetomidine and Propofol are wid...

Balakrishnan, Subhasan Jv · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.